Recurrent Rectal Cancer clinical trials

Explore recruiting recurrent rectal cancer clinical trials.

Recruiting recurrent rectal cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Recurrent Rectal Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicentre, open-label, randomized, controlled, parallel arms clinical trial of induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer (PelvEx II)

Norway, Portugal, Sweden, Netherlands, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as pre-operative treatment for locally recurrent rectal cancer (GRECCAR – PRODIGE – FRENCH) - GRECCAR 15

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Recurrent Rectal Cancer trials by city

Recurrent Rectal Cancer in Toronto Recurrent Rectal Cancer in Vancouver Recurrent Rectal Cancer in Montreal Recurrent Rectal Cancer in Calgary Recurrent Rectal Cancer in Edmonton Recurrent Rectal Cancer in Ottawa Recurrent Rectal Cancer in Winnipeg Recurrent Rectal Cancer in Quebec City Recurrent Rectal Cancer in Hamilton Recurrent Rectal Cancer in Kitchener Recurrent Rectal Cancer in London Recurrent Rectal Cancer in Halifax Recurrent Rectal Cancer in New York Recurrent Rectal Cancer in Los Angeles Recurrent Rectal Cancer in Chicago Recurrent Rectal Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease